English

Surgery Partners, INC. (SGRY) · 2026-10-26 · Daily technical & news analysis

Surgery Partners, INC. (SGRY) Technical Analysis — Chart, Levels & News

SGRY Daily Market Briefing and News-Sentiment Read — 2026-10-26

Published Oct 26, 2026 ET · Stocks & ETFs

Information only. This page covers charts, levels, and news for context, not financial or trading advice.

Automated draft. Levels and signals are rules-based and use completed bars.

S&P 500 context: SPY +0.69% on 2026-10-26; this ticker +47.59% in the same completed session.

At a glance

Surgery Partners, INC. is above its 20-day (14.82), 50-day (14.39), and 200-day (14.48) averages. The trend reads up.

Nearest support is 15.66 (-32.63% below). Nearest resistance is 24.19 (+4.07% above).

A typical day has moved about +4.60%% recently.

Support below: 15.66 | 15.07 | 14.82

Resistance above: 24.19 | 24.94 | 27.58

What changed since the last close

  • Opened with an upward gap

Based on the completed 2026-10-26 session

Signal — short-term technical (daily chart)

On the short-term daily horizon, SGRY displays a bullish technical bias driven by strong upward momentum. Conviction remains firm as the stock leads session gainers following acquisition news, though overbought indicator readings advise caution against chasing extended intraday prices.

News, Macro & Industry Context

The medium-term narrative tone is bullish. Surgery Partners announced it will be taken private by HealthSpan Partners, an affiliate of nonprofit healthcare system Bon Secours Mercy Health, in a $5.7 billion deal. Shareholders, excluding Bain Capital affiliates who own about 39% of outstanding shares and will receive buyer equity, will receive $23.50 per share in cash. HealthSpan entered into a definitive agreement to acquire a 61.24% stake for approximately $2 billion. The transaction is expected to close in the first quarter of 2027, subject to customary approvals. Meanwhile, investor rights law firm Halper Sadeh LLC is investigating whether the company is obtaining a fair price for its shareholders, and 12-month analyst price targets have been adjusted to $18.62. In the broader healthcare sector and macroeconomic backdrop, outpatient surgery operators operate within a highly consolidated environment influenced by hospital-provider partnerships, private equity healthcare consolidation trends, and regulatory oversight regarding transaction fairness.

Catalysts

Upcoming catalysts include regulatory and shareholder approvals for the pending acquisition, alongside potential developments from shareholder rights investigations and the anticipated Q1 2027 closing timeline.

Levels & Risk

Support is identified via multiple Fair Value Gap zones spanning 11.68 to 11.86, 12.57 to 12.63, 14.06 to 14.26, 14.89 to 15.07, and 15.64 to 15.66, in addition to the Volume Profile Value Area Low at 13.82 and Point of Control at 14.12. Resistance is marked by the Volume Profile Value Area High at 15.77. Invalidation of the current bullish technical setup occurs on a sustained breakdown below the value area low. Risk framing centers on deal completion uncertainties and regulatory scrutiny.

Technical Breakdown

  • WaveTrend: bullish momentum with fast above slow, deeply overbought in the fade zone.
  • SMI: bullish as the indicator prints above its signal line in overbought territory.
  • EMA trend: price trades above the EMA20 indicating an uptrend bias, while the EMA5 sits above the EMA13 reflecting short-term bullish alignment.
  • Triggers: no fresh trigger bars present on the latest completed bar.
  • Candlestick pattern: none detected on the latest completed bar.
  • Higher timeframe: no higher-timeframe extreme present.

Learn the chart

Start with the question you have, not a trading strategy. Each guide explains one part of a ticker page in plain language.

All guides

Educational technical analysis. Not financial advice. Market data may be delayed or incomplete.